Literature DB >> 8722034

Antibiotic resistance mechanisms of mutant EF-Tu species in Escherichia coli.

B Kraal1, L A Zeef, J R Mesters, K Boon, E L Vorstenbosch, L Bosch, P H Anborgh, A Parmeggiani, R Hilgenfeld.   

Abstract

Analysis of antibiotic-resistant EF-Tu mutants has revealed a connection between resistance and structural elements that participate in the GTPase switching mechanism. Both random and site-directed mutagenesis methods have yielded sets of purified mutant EF-Tu resistant to kirromycin (kirT) or pulvomycin (pulT). All kirT mutations cluster in the interface of domain 1 and 3 of EF-Tu in its GTP-bound conformation, not in that of EF-Tu.GDP. Other evidence also suggests that kirromycin binds to the interface of wild-type EF-Tu, thereby jamming the GTPase switch. Various functional studies reveal two subsequent resistance mechanisms. The first hinders kirromycin binding to EF-Tu.GTP and the second occurs after GTP hydrolysis by rejection of bound kirromycin. All pulT mutations cluster in the three-domain junction interface of EF-Tu. GTP (which is an open hole in EF-Tu.GDP) and destabilize a salt-bridge network. Pulvomycin may bind nearby and overlap with tRNA binding. Mutations show that a D99-R230 salt bridge is not essential for the transduction of the GTPase switch signal from domain 1. In vivo and in vitro studies reveal that pulvomycin sensitivity is dominant over resistance. This demands a revision of the current view of the mechanism of pulvomycin inhibition of protein synthesis and may support a translation model with two EF-Tus on the ribosome. Several mutant EF-Tu species display altered behaviour towards aminoacyl-tRNA with interesting effects on translational accuracy. KirT EF-Tu(A375T) is able to reverse the streptomycin-dependent phenotype of a ribosomal protein S12 mutant strain to streptomycin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8722034     DOI: 10.1139/o95-126

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  6 in total

Review 1.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

Review 2.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

Review 3.  Translational regulation by modifications of the elongation factor Tu.

Authors:  B Kraal; C Lippmann; C Kleanthous
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

4.  Mutations in helix 27 of the yeast Saccharomyces cerevisiae 18S rRNA affect the function of the decoding center of the ribosome.

Authors:  I V Velichutina; J Dresios; J Y Hong; C Li; A Mankin; D Synetos; S W Liebman
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

5.  Multidrug-resistant bacteria compensate for the epistasis between resistances.

Authors:  Jorge Moura de Sousa; Roberto Balbontín; Paulo Durão; Isabel Gordo
Journal:  PLoS Biol       Date:  2017-04-18       Impact factor: 8.029

6.  Genome-Wide Association Study of Nucleotide Variants Associated with Resistance to Nine Antimicrobials in Mycoplasma bovis.

Authors:  Matthew Waldner; Andrea Kinnear; Elhem Yacoub; Tim McAllister; Karen Register; Changxi Li; Murray Jelinski
Journal:  Microorganisms       Date:  2022-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.